Format

Send to

Choose Destination
JAMA. 2016 Apr 12;315(14):1516-8. doi: 10.1001/jama.2015.16984.

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation.

Author information

1
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
2
Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire3Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
3
American Board of Internal Medicine, Philadelphia, Pennsylvania.
PMID:
27115269
DOI:
10.1001/jama.2015.16984
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center